0
0

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.

4/15/2024, 8:30 PM

Current Status of Bill HR 7827

Bill HR 7827 is currently in the status of Bill Introduced since March 26, 2024. Bill HR 7827 was introduced during Congress 118 and was introduced to the House on March 26, 2024.  Bill HR 7827's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 26, 2024

Bipartisan Support of Bill HR 7827

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7827

Primary Policy Focus

Alternate Title(s) of Bill HR 7827

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.
To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.

Comments